Joseph H. Schulman

Learn More
We describe the design, fabrication, and output capabilities of a microminiature electrical stimulator that can be injected in or near nerves and muscles. Each single-channel microstimulator consists of a cylindrical glass capsule with hermetically sealed electrodes in either end (2-mm diameter x 13-mm overall length). Power and digital control data can be(More)
A family of digitally controlled devices is constructed for functional electrical stimulation in which each module is an hermetically sealed glass capsule that is small enough to be injected through the lumen of a hypodermic needle. The overall design and component characteristics of microstimulators that receive power and command signals by inductive(More)
The Alfred Mann Foundation is developing a network of up to 850 injectable devices that have stimulating, sensing and communication capabilities. Each of the devices is coordinated via radio signals a hundred times a second by an external small module. All the devices are powered by lithium-ion rechargeable batteries. The stimulating, sensing, and(More)
Thirty spastic cerebral palsy (CP) patients were involved in a double-blind quantitative study to determine the effectiveness of chronic cerebellar stimulation, (CCS) and 19 patients completed the testing. Of the 12 patients undergoing the five motor performance tests, 8 (66%) showed improvements with the stimulation. Of the 16 patients tested for active(More)
Quantitative bioengineering tests were performed on 30 spastic cerebral palsy (CP) patients who underwent chronic cerebellar stimulation (CCS) using the fully implantable pulse generator (Neurolith 601, 1.1-1.8 microC/cm2/phase). Using respiratory inductive plethysmography to measure 8 patients with paroxysmal and/or ataxic breathing patterns, 5 were shown(More)
To date, June 1, 1986, 33 spastic cerebral palsy (CP) patients have taken part in a double blind study testing the safety and efficacy of chronic cerebellar stimulation (CCS) for reduction of spasticity and improvement in function. Seven U.S. surgical centers involving ten neurosurgeons have implanted the Neurolith 601 cerebellar stimulator supplied by(More)
Twenty spastic cerebral palsy (CP) patients undergoing chronic cerebellar stimulation (CCS) for reduction of spasticity and improvement in function have participated in a double-blind study. Seven US centers involving 9 neurosurgeons (1984-6) have replaced the depleted Neurolith 601 fully implantable pulse generator (Pacesetter Systems Incorp.-Neurodyne(More)
  • 1